RELMADA THERAPEUTICS INC shareholders Q3 2023

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

RELMADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RHUMBLINE ADVISERS 1,174$3,5220.00%
Squarepoint Ops LLC 33,097$99,2910.00%
OSAIC HOLDINGS, INC. 27$810.00%
FMR LLC 84,280$252,8400.00%
SEI INVESTMENTS CO 36,230$108,6900.00%
DIMENSIONAL FUND ADVISORS LP 73,820$221,4120.00%
BANK OF AMERICA CORP /DE/ 213,535$640,6050.00%
Russell Investments Group, Ltd. 53$1590.00%
WELLS FARGO & COMPANY/MN 530$1,5900.00%
NORTHERN TRUST CORP 47,102$141,3060.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 20,343$61,0290.00%
GEODE CAPITAL MANAGEMENT, LLC 239,904$719,9050.00%
STATE STREET CORP 115,229$345,6870.00%
MILLENNIUM MANAGEMENT LLC 244,201$732,6030.00%
PRICE T ROWE ASSOCIATES INC /MD/ 159,290$4780.00%
TORONTO DOMINION BANK 81$2430.00%
DEUTSCHE BANK AG\ 4,959$14,8770.00%
Tower Research Capital LLC (TRC) 1,710$5,1300.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 12,505$37,5150.00%
External links

This page lists RELMADA THERAPEUTICS INC's shareholders in Q3 2023. To view RELMADA THERAPEUTICS INC's shareholder history, click here.